ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
심장 마커 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 123억 8,000만 달러에서 2026년에는 139억 5,000만 달러로, CAGR 12.7%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 심혈관 질환 증가, 병원 검사실 인프라 확충, 응급 심장검사 이용 확대, 바이오마커 기반 진단에 대한 의존도 증가, 검사 민감도 향상 등이 주요 요인으로 꼽힙니다.
심장 마커 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 227억 달러에 달하며, CAGR은 12.9%에 달할 전망입니다. 예측 기간 중의 성장에는 신속한 진단 검사에 대한 수요 증가, 심장 진단과 디지털 플랫폼의 통합 확대, 현장 검사 시설 확대, 첨단 바이오마커 패널 도입 확대, 정밀 심장학에 대한 집중도 강화 등이 영향을 미칠 것으로 보입니다. 예측 기간의 주요 동향으로는 고특이성 심장 마커 패널의 사용 증가, 자동 면역측정 시스템 도입 확대, 신속한 심장 진단에 대한 수요 증가, 다항목 검사 접근법 확대, 임상적 의사결정 지원 강화 등을 들 수 있습니다.
심장 마커 시장의 급격한 성장은 심장 질환의 유병률 증가에 의해 크게 견인되고 있습니다. 이 범주에는 심장의 구조와 기능에 영향을 미치고 다양한 의학적 문제를 일으키는 질환이 포함됩니다. 심장 마커는 심근경색, 협심증, 심부전, 심부전, 기타 심혈관 질환 등 다양한 심장 관련 질환의 진단 및 모니터링에 중요한 툴로 작용합니다. 그 결과, 심장 마커를 이용한 진단 검사에 대한 수요가 눈에 띄게 증가하고 있습니다. 예를 들어 영국 심장 재단의 보고서에 따르면 팬데믹 발생 이후 2022년 8월까지 영국에서 관상동맥성 심장질환으로 인한 사망자 수가 3만 명에 달하는 심각한 증가를 보였다고 합니다. 또한 2022년 8월 현재 심장질환 대기자 명단에 등록된 환자 수는 무려 34만 6천 명에 달할 전망입니다. 이처럼 심장 질환의 유병률 증가가 심장 마커 시장의 성장을 크게 견인하고 있습니다.
심장 마커 시장의 주요 기업은 고감도 트로포닌 I(hs-cTnI), NT-proBNP와 같은 심장 바이오마커와 같은 혁신적인 제품을 우선적으로 개발하여 시장 매출을 확대하기 위해 노력하고 있습니다. 이러한 바이오마커는 심혈관 질환의 진단, 분류, 치료에 매우 중요한 역할을 하고 있습니다. 예를 들어 2023년 10월, 중국의 대표적인 의료기기 및 솔루션 제공 업체인 심천 마인드 레이 바이오메디컬 일렉트로닉스(Shenzhen Mindray Biomedical Electronics Co., Ltd.)는 트로포닌 I(hs-cTnI) 및 NT-proBNP 심장 바이오 마커를 발표했습니다. hs-cTn 측정법은 심근 손상을 식별하는 데 도움이 되는 최소한의 민감도, 정확도, 신뢰성 요건을 초과합니다. 이 첨단 제품들은 심혈관 질환에 대한 치료 접근법을 강화하고 심혈관 및 관련 건강 상태 모두에서 환자의 결과를 개선할 수 있는 신뢰할 수 있는 솔루션을 제공하는 것을 목표로 하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Cardiac markers are biomolecules released into the bloodstream in response to heart muscle damage or stress, serving as crucial tools for diagnosing and monitoring a spectrum of cardiac ailments such as heart attacks, angina, and heart failure.
The primary types of cardiac markers encompass troponin, creatine kinase-MB (CK-MB), B-type natriuretic peptide (BNP), myoglobin, and various other biomarkers. Troponin, a protein released upon heart muscle damage, stands as a pivotal marker widely used for diagnosing and monitoring heart-related conditions. Diverse products in the realm of cardiac markers include reagents, instruments, and various detection methodologies such as chemiluminescence, immunofluorescence, immunochromatography, and ELISA. These markers find application across multiple indications, including myocardial infarction, congestive heart failure, acute coronary syndrome, among others. End users encompass laboratory testing facilities, hospital labs, reference labs, contract testing labs, point-of-care testing facilities, and academic institutions, where these markers play a vital role in cardiac diagnostics and monitoring.
Tariffs are impacting the cardiac marker market by increasing costs of imported reagents, analytical instruments, chemiluminescence systems, and assay consumables. Hospital labs and reference laboratories in North America and Europe are most affected due to high import dependency, while Asia-Pacific experiences cost pressures on diagnostic manufacturing. These tariffs are increasing per-test costs and slowing system upgrades. However, they are also encouraging domestic production of reagents, local instrument assembly, and development of cost-efficient cardiac testing platforms.
The cardiac marker market research report is one of a series of new reports from The Business Research Company that provides cardiac marker market statistics, including cardiac marker industry global market size, regional shares, competitors with a cardiac marker market share, detailed cardiac marker market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker industry. This cardiac marker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiac marker market size has grown rapidly in recent years. It will grow from $12.38 billion in 2025 to $13.95 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing burden of cardiovascular diseases, expansion of hospital laboratory infrastructure, rising use of emergency cardiac testing, growing reliance on biomarker-based diagnosis, improvements in assay sensitivity.
The cardiac marker market size is expected to see rapid growth in the next few years. It will grow to $22.7 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to increasing demand for faster turnaround diagnostic tests, rising integration of cardiac diagnostics with digital platforms, expansion of point-of-care testing facilities, growing adoption of advanced biomarker panels, increasing focus on precision cardiology. Major trends in the forecast period include increasing use of high-specificity cardiac marker panels, rising adoption of automated immunoassay systems, growing demand for rapid cardiac diagnosis, expansion of multiparametric testing approaches, enhanced focus on clinical decision support.
The projected surge in the cardiac marker market is strongly driven by the escalating prevalence of cardiac diseases. This category comprises conditions affecting the heart's structure or functionality, leading to a spectrum of medical issues. Cardiac markers serve as crucial tools in diagnosing and monitoring various heart-related conditions such as heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, the demand for diagnostic tests involving cardiac markers has seen a notable increase. For instance, the British Heart Foundation reported an alarming increase of 30,000 deaths from coronary heart disease in England from the pandemic's onset to August 2022. Moreover, a staggering 346,000 individuals were on cardiac waiting lists by August 2022. Hence, the escalating prevalence of cardiac diseases significantly fuels the growth of the cardiac marker market.
Leading companies in the cardiac marker market prioritize innovative products, such as high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers, to drive market revenue. These biomarkers play crucial roles in diagnosing, categorizing, and treating cardiovascular ailments. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a prominent China-based medical equipment and solutions provider, launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay surpasses minimal sensitivity, accuracy, and reliability requirements, aiding in identifying myocardial damage. These advanced products aim to enhance treatment approaches for cardiovascular diseases, offering dependable solutions to improve patient outcomes in both cardiovascular and related health contexts.
In April 2023, Abbott Laboratories, a US-based healthcare company acquired Cardiovascular Systems Inc. for an undisclosed amount. With this acquisition, Abbott will be able to better serve patients with peripheral and coronary artery disease by offering a novel and cutting-edge therapy for those with complicated cardiovascular disease. Through this acquisition, Abbott is able to expand the range of cutting-edge vascular devices it offers doctors, giving them more resources to assist patients. Cardiovascular Systems Inc. a US-based medical technology company.
Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics
North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiac marker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cardiac marker market consists of sales of C-reactive protein (CRP) and Ischemia-modified albumin (IMA). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Marker Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiac marker market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cardiac marker ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac marker market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Biomarker: Troponin; Creatine Kinase-MB (CK-MB); B-type Natriuretic Peptide (BNP); Myoglobin; Other Biomarkers
2) By Product: Reagent; Instrument; Chemiluminescence; Immunofluorescence; Immunochromatography; ELISA
3) By Indication: Myocardial Infarction; Congestive Heart Failure; Acute Coronary Syndrome; Other Indications
4) By End User: Laboratory Testing Facilities; Hospital Labs; Reference Labs; Contract Testing Labs; Point-Of-Care Testing Facilities; Academic Institutions
Subsegments:
1) By Troponin: Troponin I; Troponin T; Troponin Diagnostic Kits
2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits; CK-MB Diagnostic Panels
3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits; NT-ProBNP Test Kits; BNP Diagnostic Panels
4) By Myoglobin: Myoglobin Test Kits; Myoglobin Diagnostic Panels
5) By Other Biomarkers: Ischemia Modified Albumin (IMA); Heart Fatty Acid Binding Protein (HFABP); C-Reactive Protein (CRP)
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
2.4. Global Cardiac Marker Market Attractiveness Scoring And Analysis
2.4.1. Overview of Market Attractiveness Framework
2.4.2. Quantitative Scoring Methodology
2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations
3. Cardiac Marker Market Supply Chain Analysis
3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users
4. Global Cardiac Marker Market Trends And Strategies
4.1. Key Technologies & Future Trends
4.1.1 Biotechnology, Genomics And Precision Medicine
4.1.2 Digitalization, Cloud, Big Data And Cybersecurity
4.1.3 Artificial Intelligence And Autonomous Intelligence
4.1.4 Industry 4.0 And Intelligent Manufacturing
4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Use Of High-Specificity Cardiac Marker Panels
4.2.2 Rising Adoption Of Automated Immunoassay Systems
4.2.3 Growing Demand For Rapid Cardiac Diagnosis
4.2.4 Expansion Of Multiparametric Testing Approaches
4.2.5 Enhanced Focus On Clinical Decision Support
5. Cardiac Marker Market Analysis Of End Use Industries
5.1 Hospital Labs
5.2 Laboratory Testing Facilities
5.3 Reference Laboratories
5.4 Point-Of-Care Testing Facilities
5.5 Academic Institutions
6. Cardiac Marker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Cardiac Marker Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Cardiac Marker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Cardiac Marker Market Size, Comparisons And Growth Rate Analysis
7.3. Global Cardiac Marker Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Cardiac Marker Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Cardiac Marker Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Cardiac Marker Market Segmentation
9.1. Global Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Cardiac Marker Market, Sub-Segmentation Of Troponin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Troponin I, Troponin T, Troponin Diagnostic Kits
9.6. Global Cardiac Marker Market, Sub-Segmentation Of Creatine Kinase-MB (CK-MB), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
CK-MB Test Kits, CK-MB Diagnostic Panels
9.7. Global Cardiac Marker Market, Sub-Segmentation Of B-Type Natriuretic Peptide (BNP), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels
9.8. Global Cardiac Marker Market, Sub-Segmentation Of Myoglobin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Myoglobin Test Kits, Myoglobin Diagnostic Panels
9.9. Global Cardiac Marker Market, Sub-Segmentation Of Other Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)
10. Cardiac Marker Market Regional And Country Analysis
10.1. Global Cardiac Marker Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Cardiac Marker Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Cardiac Marker Market
11.1. Asia-Pacific Cardiac Marker Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Cardiac Marker Market
12.1. China Cardiac Marker Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Cardiac Marker Market
13.1. India Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Cardiac Marker Market
14.1. Japan Cardiac Marker Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Cardiac Marker Market
15.1. Australia Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Cardiac Marker Market
16.1. Indonesia Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Cardiac Marker Market
17.1. South Korea Cardiac Marker Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Cardiac Marker Market
18.1. Taiwan Cardiac Marker Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Cardiac Marker Market
19.1. South East Asia Cardiac Marker Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Cardiac Marker Market
20.1. Western Europe Cardiac Marker Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Cardiac Marker Market
21.1. UK Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Cardiac Marker Market
22.1. Germany Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Cardiac Marker Market
23.1. France Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Cardiac Marker Market
24.1. Italy Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Cardiac Marker Market
25.1. Spain Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Cardiac Marker Market
26.1. Eastern Europe Cardiac Marker Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Cardiac Marker Market
27.1. Russia Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Cardiac Marker Market
28.1. North America Cardiac Marker Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Cardiac Marker Market
29.1. USA Cardiac Marker Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Cardiac Marker Market
30.1. Canada Cardiac Marker Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Cardiac Marker Market
31.1. South America Cardiac Marker Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Cardiac Marker Market
32.1. Brazil Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Cardiac Marker Market
33.1. Middle East Cardiac Marker Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Cardiac Marker Market
34.1. Africa Cardiac Marker Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Cardiac Marker Market, Segmentation By Biomarker, Segmentation By Product, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Cardiac Marker Market Regulatory and Investment Landscape
36. Cardiac Marker Market Competitive Landscape And Company Profiles
36.1. Cardiac Marker Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Cardiac Marker Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Cardiac Marker Market Company Profiles
36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
36.3.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
37. Cardiac Marker Market Other Major And Innovative Companies
